back to US directory
us clinical guidance

Ectopic pregnancy and early pregnancy loss

ACOG evaluation of pregnancy of unknown location, ectopic-pregnancy urgency and patient-centered management of confirmed early pregnancy loss.

JurisdictionUnited States
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceUnited States healthcare professionals
This is an iatroX educational summary of named United States sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Use the named authority, current FDA labeling, applicable state law, payer rules and local protocol where relevant.

Scope of this summary

Pregnant patients with first-trimester pain, bleeding, uncertain viability or confirmed early pregnancy loss. Gestational trophoblastic disease, later pregnancy loss and detailed Rh(D) prophylaxis are outside this combined overview and require the current dedicated guidance.
sources for this section:ACOG PB 193ACOG PB 200

The Bottom Line

  • Exclude ectopic pregnancy before labeling an intrauterine pregnancy loss when pregnancy location is uncertain; one equivocal ultrasound or single human chorionic gonadotropin value is often insufficient.
  • Use symptoms, hemodynamic status, transvaginal ultrasound and serial quantitative human chorionic gonadotropin together for a pregnancy of unknown location, with explicit follow-up until a diagnosis or resolution is established.
  • A hemodynamically unstable or ruptured ectopic pregnancy requires immediate surgical management, while selected stable patients may be eligible for medication or carefully monitored expectant management.
  • Once early pregnancy loss is confirmed using accepted diagnostic criteria, expectant, medication and uterine-evacuation options are all reasonable for appropriate patients and should reflect preference and clinical urgency.
  • Do not use terminology that assigns blame: most early pregnancy losses are not caused by ordinary activity, and counseling should address grief, future fertility and recurrence questions.
sources for this section:ACOG PB 193ACOG PB 200

Practical clinical workflow

1
Triage bleeding amount, pain location, syncope, vital signs, gestational dating, prior ectopic pregnancy, tubal surgery, fertility treatment, contraception and blood-group information.
2
Perform pregnancy testing, quantitative human chorionic gonadotropin and transvaginal ultrasound according to presentation, adding blood count, type and screen, examination and crossmatch when bleeding or instability warrants.
3
For uncertain findings, document the exact follow-up interval for repeat testing, who will review results and how the patient can obtain emergency care rather than offering false reassurance.
4
For confirmed stable loss, compare time to completion, bleeding, pain, likelihood of additional intervention, privacy and follow-up for expectant, medication and procedural options.
5
Confirm clinical resolution by the selected pathway and provide contraception if desired, preconception advice, bereavement support and review after pathology or genetic findings when obtained.
sources for this section:ACOG PB 193ACOG PB 200

Safety boundaries and escalation

  • Shock, peritoneal signs, syncope, severe unilateral pain, shoulder pain or substantial ongoing bleeding requires immediate emergency and gynecologic management for possible rupture or hemorrhage.
  • Methotrexate requires reliable follow-up and screening for contraindications; worsening pain, inadequate hormone decline or loss to monitoring can become life threatening.
  • Fever, foul discharge, persistent heavy bleeding or clinical deterioration after miscarriage management requires urgent review for infection, retained tissue or hemorrhage.
  • Rh(D) immune-globulin practice has changed through focused updates; verify the current ACOG recommendation and local protocol rather than importing an older universal rule into this summary.
sources for this section:ACOG PB 193ACOG PB 200

Localization

This is an ACOG-based US pathway. Ultrasound availability, emergency gynecology access, medication and procedural-law constraints, and Rh(D) protocols vary by state and institution; legal restrictions must never delay stabilization of an emergency.
sources for this section:ACOG PB 193ACOG PB 200

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. American College of Obstetricians and GynecologistsTubal Ectopic PregnancyPractice Bulletin No. 193 路 Reaffirmed 2025 路 published 2018-03-01 路 accessed 2026-08-20
    view source
  2. American College of Obstetricians and GynecologistsEarly Pregnancy LossPractice Bulletin No. 200 路 Reaffirmed 2025; read with focused updates listed by ACOG 路 published 2018-11-01 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the US question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.